Wall Street Close: Nasdaq prints mild gains amid subdued session

US shares began the trading week on a sluggish note amid confusion over the US Federal Reserve (Fed) next moves. Also contributing to the subdued session could be the mixed headlines relating to the taxes, China and the coronavirus (COVID-19) amid a light calendar before the key US inflation data and the ECB events set for release on Thursday.

Although Friday’s US NFP eased tapering fears, US Treasury Secretary Janet Yellen’s mixed comments over the inflation woes and the preference for the higher rates troubled investors on Monday. Also probing the bulls was a 15% corporate tax agreed by the Group of Seven (G7) as well as escalating tensions between the Western friends and China.

Amid these plays, mildly positive technology shares, amid chatters over chip shortage, managed to keep Nasdaq positive, up 0.49% or 67.23 points to 13,881.72. However, S&P 500 Futures and Dow Jones Industrial Average (DJI) were on the back foot, losing 0.06% and 0.36% respectively, while ending the day near 4,226.52 and 34,630.24.

Company-specific news highlights Moderna’s 7% rally on the drug manufacturer’s application to the European Union (EU) and Canadian government for extending emergency authorization for its covid vaccine to 12-15 years of adolescents. Further, Eli Lilly gained around 10% whereas Biogen jumped over 35% on news relating to a discovery of Alzheimer's treatment.

It’s worth noting that Morgan Stanley’s rating downgrade to Progressive combats Fitch’s upgrade to Amazon and affirmation of AA/F1+ for Walmart.

Against this backdrop, the US dollar index (DXY) flashed second consecutive daily losses whereas the US Treasury yields struggled around 1.56% by the end of Monday’s North American session.

Looking forward, global markets may remain tepid ahead of Thursday’s US inflation and ECB events. However, intermediate clues relating to inflation and the Fed’s next moves may entertain market players.